Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15121960 | Publishing Date : 27-Jan-2020 | No. of pages : 130
Detailed TOC of Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CLIA Method
1.4.3 ELISA Method
1.5 Market by Application
1.5.1 Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2020 VS 2026
1.5.2 Screening
1.5.3 Post-treatment Monitoring
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Prostate-specific Antigen (PSA) Testing Market Perspective (2015-2026)
2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Regions
2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Share by Regions (2015-2020)
2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prostate-specific Antigen (PSA) Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate-specific Antigen (PSA) Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Market Size
3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2015-2020)
3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
3.2.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2019
3.3 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
3.4 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
3.5 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2015-2020)
4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2021-2026)
5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application (2015-2026)
5.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
6.2 Prostate-specific Antigen (PSA) Testing Key Players in North America (2019-2020)
6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
7.2 Prostate-specific Antigen (PSA) Testing Key Players in Europe (2019-2020)
7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
8 China
8.1 China Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
8.2 Prostate-specific Antigen (PSA) Testing Key Players in China (2019-2020)
8.3 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
8.4 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
9.2 Prostate-specific Antigen (PSA) Testing Key Players in Japan (2019-2020)
9.3 Japan Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
9.4 Japan Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
10.2 Prostate-specific Antigen (PSA) Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
11 India
11.1 India Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
11.2 Prostate-specific Antigen (PSA) Testing Key Players in India (2019-2020)
11.3 India Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
11.4 India Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
12.2 Prostate-specific Antigen (PSA) Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
12.4 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
13.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Details
13.2.2 Boston Scientific Corporation Business Overview and Its Total Revenue
13.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
13.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.2.5 Boston Scientific Corporation Recent Development
13.3 Bayer AG
13.3.1 Bayer AG Company Details
13.3.2 Bayer AG Business Overview and Its Total Revenue
13.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
13.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.3.5 Bayer AG Recent Development
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Details
13.4.2 Siemens Healthcare Business Overview and Its Total Revenue
13.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
13.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.4.5 Siemens Healthcare Recent Development
13.5 DiaSorin
13.5.1 DiaSorin Company Details
13.5.2 DiaSorin Business Overview and Its Total Revenue
13.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
13.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.5.5 DiaSorin Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview and Its Total Revenue
13.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
13.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Beckman Coulter
13.7.1 Beckman Coulter Company Details
13.7.2 Beckman Coulter Business Overview and Its Total Revenue
13.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
13.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.7.5 Beckman Coulter Recent Development
13.8 PerkinElmer
13.8.1 PerkinElmer Company Details
13.8.2 PerkinElmer Business Overview and Its Total Revenue
13.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
13.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.8.5 PerkinElmer Recent Development
13.9 Tosoh
13.9.1 Tosoh Company Details
13.9.2 Tosoh Business Overview and Its Total Revenue
13.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
13.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.9.5 Tosoh Recent Development
13.10 Ortho Clinical
13.10.1 Ortho Clinical Company Details
13.10.2 Ortho Clinical Business Overview and Its Total Revenue
13.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
13.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.10.5 Ortho Clinical Recent Development
13.11 Fujirebio
10.11.1 Fujirebio Company Details
10.11.2 Fujirebio Business Overview and Its Total Revenue
10.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
10.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.11.5 Fujirebio Recent Development
13.12 Mediwatch
10.12.1 Mediwatch Company Details
10.12.2 Mediwatch Business Overview and Its Total Revenue
10.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
10.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.12.5 Mediwatch Recent Development
13.13 BodiTech
10.13.1 BodiTech Company Details
10.13.2 BodiTech Business Overview and Its Total Revenue
10.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
10.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.13.5 BodiTech Recent Development
13.14 Bristol-Myers Squibb Company
10.14.1 Bristol-Myers Squibb Company Company Details
10.14.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
10.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
10.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.14.5 Bristol-Myers Squibb Company Recent Development
13.15 GE Healthcare
10.15.1 GE Healthcare Company Details
10.15.2 GE Healthcare Business Overview and Its Total Revenue
10.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
10.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.15.5 GE Healthcare Recent Development
13.16 Endocare
10.16.1 Endocare Company Details
10.16.2 Endocare Business Overview and Its Total Revenue
10.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
10.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.16.5 Endocare Recent Development
13.17 Merck&Co.
10.17.1 Merck&Co. Company Details
10.17.2 Merck&Co. Business Overview and Its Total Revenue
10.17.3 Merck&Co. Prostate-specific Antigen (PSA) Testing Introduction
10.17.4 Merck&Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.17.5 Merck&Co. Recent Development
13.18 Medtronic
10.18.1 Medtronic Company Details
10.18.2 Medtronic Business Overview and Its Total Revenue
10.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
10.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.18.5 Medtronic Recent Development
13.19 Sanofi-Aventis SA
10.19.1 Sanofi-Aventis SA Company Details
10.19.2 Sanofi-Aventis SA Business Overview and Its Total Revenue
10.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
10.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.19.5 Sanofi-Aventis SA Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Prostate-specific Antigen (PSA) Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
Table 3. Ranking of Global Top Prostate-specific Antigen (PSA) Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CLIA Method
Table 6. Key Players of ELISA Method
Table 7. Global Prostate-specific Antigen (PSA) Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2015-2020)
Table 11. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Prostate-specific Antigen (PSA) Testing Market Growth Strategy
Table 17. Main Points Interviewed from Key Prostate-specific Antigen (PSA) Testing Players
Table 18. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2015-2020) (Million US$)
Table 19. Global Prostate-specific Antigen (PSA) Testing Market Share by Players (2015-2020)
Table 20. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2019)
Table 21. Global Prostate-specific Antigen (PSA) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
Table 24. Date of Enter into Prostate-specific Antigen (PSA) Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Type (2015-2020)
Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Application (2015-2020)
Table 30. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 31. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Application (2021-2026)
Table 32. North America Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 34. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 35. North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 36. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 37. North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 38. Europe Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 40. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 42. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 44. China Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 45. China Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 46. China Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 47. China Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 48. China Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 49. China Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 50. Japan Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 52. Japan Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 54. Japan Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 58. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 60. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 62. India Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 63. India Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 64. India Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 65. India Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 66. India Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 67. India Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 70. Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 72. Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott Product
Table 77. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 78. Abbott Recent Development
Table 79. Boston Scientific Corporation Company Details
Table 80. Boston Scientific Corporation Business Overview
Table 81. Boston Scientific Corporation Product
Table 82. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 83. Boston Scientific Corporation Recent Development
Table 84. Bayer AG Company Details
Table 85. Bayer AG Business Overview
Table 86. Bayer AG Product
Table 87. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 88. Bayer AG Recent Development
Table 89. Siemens Healthcare Company Details
Table 90. Siemens Healthcare Business Overview
Table 91. Siemens Healthcare Product
Table 92. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 93. Siemens Healthcare Recent Development
Table 94. DiaSorin Company Details
Table 95. DiaSorin Business Overview
Table 96. DiaSorin Product
Table 97. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 98. DiaSorin Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. Beckman Coulter Company Details
Table 105. Beckman Coulter Business Overview
Table 106. Beckman Coulter Product
Table 107. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 108. Beckman Coulter Recent Development
Table 109. PerkinElmer Business Overview
Table 110. PerkinElmer Product
Table 111. PerkinElmer Company Details
Table 112. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 113. PerkinElmer Recent Development
Table 114. Tosoh Company Details
Table 115. Tosoh Business Overview
Table 116. Tosoh Product
Table 117. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 118. Tosoh Recent Development
Table 119. Ortho Clinical Company Details
Table 120. Ortho Clinical Business Overview
Table 121. Ortho Clinical Product
Table 122. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 123. Ortho Clinical Recent Development
Table 124. Fujirebio Company Details
Table 125. Fujirebio Business Overview
Table 126. Fujirebio Product
Table 127. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 128. Fujirebio Recent Development
Table 129. Mediwatch Company Details
Table 130. Mediwatch Business Overview
Table 131. Mediwatch Product
Table 132. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 133. Mediwatch Recent Development
Table 134. BodiTech Company Details
Table 135. BodiTech Business Overview
Table 136. BodiTech Product
Table 137. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 138. BodiTech Recent Development
Table 139. Bristol-Myers Squibb Company Company Details
Table 140. Bristol-Myers Squibb Company Business Overview
Table 141. Bristol-Myers Squibb Company Product
Table 142. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 143. Bristol-Myers Squibb Company Recent Development
Table 144. GE Healthcare Company Details
Table 145. GE Healthcare Business Overview
Table 146. GE Healthcare Product
Table 147. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 148. GE Healthcare Recent Development
Table 149. Endocare Company Details
Table 150. Endocare Business Overview
Table 151. Endocare Product
Table 152. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 153. Endocare Recent Development
Table 154. Merck&Co. Company Details
Table 155. Merck&Co. Business Overview
Table 156. Merck&Co. Product
Table 157. Merck&Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 158. Merck&Co. Recent Development
Table 159. Medtronic Company Details
Table 160. Medtronic Business Overview
Table 161. Medtronic Product
Table 162. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 163. Medtronic Recent Development
Table 164. Sanofi-Aventis SA Company Details
Table 165. Sanofi-Aventis SA Business Overview
Table 166. Sanofi-Aventis SA Product
Table 167. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 168. Sanofi-Aventis SA Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2020 VS 2026
Figure 2. CLIA Method Features
Figure 3. ELISA Method Features
Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2020 VS 2026
Figure 5. Screening Case Studies
Figure 6. Post-treatment Monitoring Case Studies
Figure 7. Other Case Studies
Figure 8. Prostate-specific Antigen (PSA) Testing Report Years Considered
Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions: 2020 VS 2026
Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2019
Figure 14. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2019
Figure 16. North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 25. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 27. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 29. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 31. DiaSorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 33. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 35. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 37. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 39. Tosoh Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 41. Ortho Clinical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 43. Fujirebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 45. Mediwatch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 47. BodiTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 49. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 51. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 53. Endocare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 55. Merck&Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merck&Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 57. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 59. Sanofi-Aventis SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Keyplayers in Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2020-2026
AbbottBoston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck&Co.
Medtronic
Sanofi-Aventis SA